A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.

MLA

Selle, F., et al. “A Phase II Trial of High-Dose Chemotherapy (HDCT) Supported by Hematopoietic Stem-Cell Transplantation (HSCT) in Germ-Cell Tumors (GCTs) Patients Failing Cisplatin-Based Chemotherapy: The Multicentric TAXIF II Study.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 25, no. 9, Sept. 2014, pp. 1775–82. EBSCOhost, https://doi.org/10.1093/annonc/mdu198.

APA

Selle, F., Wittnebel, S., Biron, P., Gravis, G., Roubaud, G., Bui, B. N., Delva, R., Bay, J. O., Fléchon, A., Geoffrois, L., Caty, A., Soares, D. G., de Revel, T., Fizazi, K., Gligorov, J., Micléa, J. M., Dubot, C., Provent, S., Temby, I., … Lotz, J. P. (2014). A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 25(9), 1775–1782. https://doi.org/10.1093/annonc/mdu198

Chicago

Selle, F, S Wittnebel, P Biron, G Gravis, G Roubaud, B N Bui, R Delva, et al. 2014. “A Phase II Trial of High-Dose Chemotherapy (HDCT) Supported by Hematopoietic Stem-Cell Transplantation (HSCT) in Germ-Cell Tumors (GCTs) Patients Failing Cisplatin-Based Chemotherapy: The Multicentric TAXIF II Study.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 25 (9): 1775–82. doi:10.1093/annonc/mdu198.